|
Anti-sense Oligonucleotide Targets Insulin Receptor Isoform A
IR-A ASO targets the exon 10-12 junction in of IR-A mRNA.
Invention Summary:
Breast cancer is one of the most common cancers among women, and while effective treatment options exist, there remains a critical need to enhance their efficacy and reduce their off-target effects to minimize toxicity. Expression of Insulin receptor-A (IR-A),...
Published: 4/8/2025
|
Inventor(s): Teresa Wood, Christopher Galifi
Keywords(s):
Category(s): Technology Classifications > Cancer, Technology Classifications > Therapeutics
|
